Congress Asks FDA Science Board Subcommittee To Quantify Agency Funding Needs
This article was originally published in The Pink Sheet Daily
Panel members are well qualified to make budgetary recommendations, chairwoman Gail Cassell of Lilly tells “The Pink Sheet” DAILY.
You may also be interested in...
Agency again seeks user fees to pay for review of generic drug applications and direct-to-consumer TV ads; proposes $984 million budget for human drugs and biologics.
Ten-year budget review request comes just a week before HHS releases FDA funding proposals for 2009.
Drug makers need to continue investing in early-stage research to unveil the next $1 billion-plus drug, panelists at the Argyle conference agree.